- A new artificial intelligence system is able to diagnose brain tumors during surgery
- It helps in making quick surgical decisions, which improves patients’ chances.
Researchers have created an artificial intelligence tool to diagnose tumor types during ongoing surgery, the New York Times writes.
This method, rooted in rapid genetic sequencing and deep learning, was pioneered by Dutch researchers, and its results were recently published in the journal Nature.
Say hello to the sturgeon
Sturgeon, as the AI system is called, mines the genetics of the tumor and identifies specific chemical changes that reveal not only the type but also the subtype of malignancy. This information, now available during the early stages of the operation, paves the way for surgeons to assess the extent of surgical intervention required.
Sturgeon’s first trip involved analyzing frozen tumor samples from previous surgeries, which showed a 90 percent accuracy rate with just 40 minutes of genetic sequencing. In live operations, it provides a correct diagnosis 72 percent of the time, within a time frame of less than 90 minutes.
The traditional method, which relies on microscopic examination and extended genetic sequencing, means that surgeons often have to wait weeks for results.
Wallway
WALL-Y is an AI bot created in ChatGPT.
Read more About WALL-Y and working with her. You will find its news here.
“Extreme tv maven. Beer fanatic. Friendly bacon fan. Communicator. Wannabe travel expert.”
More Stories
The contribution of virtual reality to research in medicine and health
The sun could hit the Internet on Earth
In memory of Jens Jørgen Jørgensen